Orthopaedic Industry News & Orthopaedic Company News | Orthogate Professionals

Here are four takeaways:

1. Initia features Kyocera Medical's BIOCERAM AZU zirconia-toughened alumina ceramic femoral heads.

2. Surgeons may also purchase the system with cobalt chrome femoral heads, which are matched to cross-linked polyethylene acetabular liners.

3. The system is available in 16 taper-wedge stem sizes, with 12 of those available in the United States.

4. Kyocera Medical manufactures implantable systems and advanced ceramic components.

More articles on devices:
Aurora Spine, Zimmer Biomet, DePuy Synthes & more: 11 key notes

Here are five highlights:

1. The HoloLens guides surgeons to more accurately place pedicle screws.

2. The device is also intended to help surgeons avoid complications, like neural damage or implant loosening, by providing proper pedicle screw placement.

3. The HoloLens offers a 3-D CT scan, which provides a trajectory for screw placement.

4. Dr. Henrique Lampert and Dr. Bruno Gobbato, of the Instituto de Ortopedia e Traumatologia de Jaraguá do Su, have used the device.

Here are four quick points:

1. The Aurora Spine Mobile App is designed to provide information on the company's products.

2. The company wanted to expand its reach, offering all product lines and surgical technique guides on a user's mobile device.

3. The app includes 3-D models as well as outlines features for every implant.

4. Users may access the app on Apple and Android devices.

More articles on devices:
Aurora Spine, Zimmer Biomet, DePuy Synthes & more: 11 key notes

NEW YORK, Dec. 5, 2016 /PRNewswire/ -- Global biological implant market is anticipated to reach USD 9.8 billion by 2024, according to a new report by Grand View Research, Inc. Biological implant market is driven by rise in adoption of grafts and organ substitutes for reconstructive surgeries for various clinical applications such as cardiovascular, orthopedic and other soft tissue repair. The main challenge associated with the use of these products is to incorporate such a material that can specifically adapt to the biology of the surrounding environment in order to accelerate regeneration and repair. To overcome this challenge, research endeavors are carried out in order to develop such devices from biological source thus affecting industrial growth in the coming years.

Albany, NY -- (SBWIRE) -- 12/05/2016 -- Interspinous spacers sometimes also called as Interspinous process decompression systems, are the devices implanted between vertebral spinous processes. These spacers are made up of a very strong but lightweight metal (titanium) which is biocompatible in the human body. These devices are imbedded in body to confine painful motion else enabling normal motion and to treat lumbar spinal stenosis, discogenic low-back pain, facet syndrome, disc herniations, and non-traumatic instability. Lumbar spinal stenosis is a thinning of the spinal canal in the lower back which causes compression on nerves and it is developed gradually with age.

Dental Crown and Bridges Market: Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021

This press release was orginally distributed by SBWire

Sarasota, FL -- (SBWIRE) -- 12/05/2016 -- Crowns and bridges are a treatment through which teeth conditions are repaired. In crown treatment, new teeth are implanted on the decaying or damaged tooth. In bridges treatment, a gap between teeth is filled by implanting a specific number of teeth in the gaps. The crowns and bridges are fixed onto existing teeth and can only be removed by a professional. These devices are usually made from the ceramic material but sometimes gold, silver or acrylic can also be used.

LONDON – Scientists are taking the battle to prevent HIV to the next level with large-scale trials set to start using injections to protect vulnerable groups such as gay men and women in Africa for at least two months.

Further down the road, the hope is to produce matchstick-sized implants containing slow-release drugs - similar to existing under-the-skin contraceptive devices - that could offer year-long protection.

Companies with drugs involved include GlaxoSmithKline, Gilead Sciences and Merck.

The initiatives build on the success of Gilead's once-daily pill Truvada, which has proved remarkably effective at stopping HIV infection during sex.